Magenta Therapeutics Inc (MGTA)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

100 TECHNOLOGY SQUARE CAMBRIDGE, MA 02139

Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of immune system reset through stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant community to revolutionize immune reset for more patients.

Data as of 2021-09-19 13:15:17 -0400
Market Cap456.239 Million Shares Outstanding58.567 Million Avg 30-day Volume280.889 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.36 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.55215 52-week High/Low14.2 / 5.89 Next Earnings Date2021-11-04 Price to Cash FLow (P/CF) -28.0807
Data provided by IEX Cloud
View SEC Filings from MGTA instead.

View recent insider trading info

Magenta Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding MGTA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MGTA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

49.6 Thousand total shares from 7 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GARDNER JASON SEE REMARKS

  • Officer
 938,954 2021-09-16 4

BEETHAM THOMAS W. SEE REMARKS

  • Officer
 13,897 2021-09-16 4

MAHONEY STEPHEN F. SEE REMARKS

  • Officer
 14,264 2021-09-16 4

STANTS KRISTEN CHIEF PEOPLE OFFICER

  • Officer
 14,264 2021-09-16 4

OLSON LISA SEE REMARKS

  • Officer
 14,264 2021-09-16 5

NICHOLS DAVID WAYNE CHIEF TECHNICAL OFFICER

  • Officer
 14,306 2021-09-16 5

DEARDORF CAREN CHIEF COMMERCIAL OFFICER

  • Officer
 13,762 2021-09-16 4

THIRD ROCK VENTURES IV, L.P.

THIRD ROCK VENTURES GP IV, L.P.

TRV GP IV, LLC

  • 10% Owner
 6,758,204 2021-08-25 1

BONNEY MICHAEL W

  • Director
 18,188 2021-06-01 1

BORISY ALEXIS

  • Director
 18,188 2021-06-01 1

RONNEBERG AMY L

  • Director
 18,188 2021-06-01 1

BOOTH BRUCE

  • Director
 18,188 2021-06-01 1

DANIEL THOMAS O

  • Director
 18,188 2021-06-01 1

LAWTON ALISON FRANCES

  • Director
 18,188 2021-06-01 3

ALBERS JEFFREY W.

  • Director
 18,188 2021-06-01 1

SCADDEN DAVID

  • Director
 18,188 2021-06-01 1

MCGEORGE ANNE

  • Director
 18,188 2021-06-01 1

ATLAS VENTURE FUND X, L.P.

  • 10% Owner
 No longer subject to file 2021-02-11 1

ZDRAVESKI ZORAN SEE REMARKS

  • Officer
 0 2021-02-11 1

DAVIS JOHN C. JR SEE REMARKS

  • Officer
 0 2021-02-11 1

DRISCOLL CINDY SEE REMARKS

  • Officer
 0 2020-10-01 1

ATLAS VENTURE OPPORTUNITY FUND I, L.P.

ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P.

ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLC

  • SEE REMARKSSEE REMARKSSEE REMARKS
 1,250,000 2020-06-29 0

BYERS BLAKE

  • Director
 0 2020-06-05 0

RYAN JASON SEE REMARKS

  • Officer
 0 2020-02-10 0

ISACSON CHRISTINA K. CHIEF BUSINESS OFFICER

  • Officer
 0 2020-02-10 0

COOKE MICHAEL P. CHIEF SCIENTIFIC OFFICER

240,523 2019-12-02 0

ATLAS VENTURE FUND X, L.P.

ATLAS VENTURE ASSOCIATES X, L.P.

ATLAS VENTURE ASSOCIATES X, LLC

  • 10% Owner
 4,117,125 2019-03-20 1

GV 2016 GP, L.L.C.

GV 2016 GP, L.P.

GV 2016, L.P.

ALPHABET INC.

  • 10% Owner
 No longer subject to file 2018-06-25 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

STANTS KRISTEN - Officer CHIEF PEOPLE OFFICER

2021-09-20 17:08:51 -0400 2021-09-16 S 5,736 $6.73 d 14,264 direct

NICHOLS DAVID WAYNE - Officer CHIEF TECHNICAL OFFICER

2021-09-20 17:00:10 -0400 2021-09-16 S 5,694 $6.73 d 14,306 direct

GARDNER JASON - Officer SEE REMARKS

2021-09-20 17:00:50 -0400 2021-09-16 S 14,340 $6.73 d 286,872 direct

DEARDORF CAREN - Officer CHIEF COMMERCIAL OFFICER

2021-09-20 17:02:20 -0400 2021-09-16 S 6,238 $6.73 d 13,762 direct

OLSON LISA - Officer SEE REMARKS

2021-09-20 17:00:13 -0400 2021-09-16 S 5,736 $6.73 d 14,264 direct

MAHONEY STEPHEN F. - Officer SEE REMARKS

2021-09-20 17:02:30 -0400 2021-09-16 S 5,736 $6.73 d 14,264 direct

BEETHAM THOMAS W. - Officer SEE REMARKS

2021-09-20 17:00:26 -0400 2021-09-16 S 6,103 $6.73 d 13,897 direct

DEARDORF CAREN - Officer CHIEF COMMERCIAL OFFICER

2021-09-16 19:41:06 -0400 2021-09-14 A 20,000 a 20,000 direct -5.6483 0.0 1 -5.6483 2

NICHOLS DAVID WAYNE - Officer CHIEF TECHNICAL OFFICER

2021-09-16 19:39:19 -0400 2021-09-14 A 20,000 a 20,000 direct -5.6483 0.0 1 -5.6483 2

OLSON LISA - Officer SEE REMARKS

2021-09-16 19:43:39 -0400 2021-09-14 A 20,000 a 20,000 direct -5.6483 0.0 1 -5.6483 2

STANTS KRISTEN - Officer CHIEF PEOPLE OFFICER

2021-09-16 19:42:32 -0400 2021-09-14 A 20,000 a 20,000 direct -5.6483 0.0 1 -5.6483 2

GARDNER JASON - Director - Officer SEE REMARKS

2021-09-16 19:40:31 -0400 2021-09-14 A 50,000 a 301,212 direct -5.6483 0.0 1 -5.6483 2

MAHONEY STEPHEN F. - Officer SEE REMARKS

2021-09-16 19:41:02 -0400 2021-09-14 A 20,000 a 20,000 direct -5.6483 0.0 1 -5.6483 2

BEETHAM THOMAS W. - Officer SEE REMARKS

2021-09-16 19:39:01 -0400 2021-09-14 A 20,000 a 20,000 direct -5.6483 0.0 1 -5.6483 2

THIRD ROCK VENTURES IV, L.P. - > 10% Owner

THIRD ROCK VENTURES GP IV, L.P. - > 10% Owner

TRV GP IV, LLC - > 10% Owner

2021-08-26 17:54:07 -0400 2021-08-25 J 1,250,000 d 6,758,204 direct 1.92 4.32 5.76 5 0.0 1

STANTS KRISTEN - Officer CHIEF PEOPLE OFFICER

2021-08-03 16:34:45 -0400 2021-08-02 A 67,500 a 67,500 direct

GARDNER JASON - Director - Officer SEE REMARKS

2021-08-03 16:33:06 -0400 2021-08-02 A 112,500 a 112,500 direct

OLSON LISA - Officer SEE REMARKS

2021-08-03 16:39:19 -0400 2021-08-02 A 12,500 a 12,500 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
MAGENTA THERAPEUTICS INC MGTA 2021-09-22 22:15:03 UTC -0.3759 0.4459 1100000
MAGENTA THERAPEUTICS INC MGTA 2021-09-22 21:45:03 UTC -0.3759 0.4459 1100000
MAGENTA THERAPEUTICS INC MGTA 2021-09-22 21:15:03 UTC -0.3759 0.4459 1100000
MAGENTA THERAPEUTICS INC MGTA 2021-09-22 20:45:02 UTC -0.3759 0.4459 1100000
MAGENTA THERAPEUTICS INC MGTA 2021-09-22 20:15:03 UTC -0.3759 0.4459 1100000
MAGENTA THERAPEUTICS INC MGTA 2021-09-22 19:45:03 UTC -0.3759 0.4459 1100000
MAGENTA THERAPEUTICS INC MGTA 2021-09-22 19:15:03 UTC -0.3759 0.4459 1100000
MAGENTA THERAPEUTICS INC MGTA 2021-09-22 18:45:03 UTC -0.2852 0.3552 1100000
MAGENTA THERAPEUTICS INC MGTA 2021-09-22 18:15:04 UTC -0.2852 0.3552 1100000
MAGENTA THERAPEUTICS INC MGTA 2021-09-22 17:45:04 UTC -0.2852 0.3552 1100000
MAGENTA THERAPEUTICS INC MGTA 2021-09-22 17:15:03 UTC -0.2852 0.3552 1100000
MAGENTA THERAPEUTICS INC MGTA 2021-09-22 16:45:03 UTC -0.2852 0.3552 1200000
MAGENTA THERAPEUTICS INC MGTA 2021-09-22 16:15:03 UTC -0.2852 0.3552 1200000
MAGENTA THERAPEUTICS INC MGTA 2021-09-22 15:45:03 UTC -0.2852 0.3552 1200000
MAGENTA THERAPEUTICS INC MGTA 2021-09-22 15:15:03 UTC -0.2852 0.3552 1200000
MAGENTA THERAPEUTICS INC MGTA 2021-09-22 14:45:03 UTC -0.2666 0.3366 1200000
MAGENTA THERAPEUTICS INC MGTA 2021-09-22 14:15:03 UTC -0.2666 0.3366 1200000
MAGENTA THERAPEUTICS INC MGTA 2021-09-22 13:45:04 UTC -0.2666 0.3366 1200000
MAGENTA THERAPEUTICS INC MGTA 2021-09-22 13:15:03 UTC -0.2666 0.3366 1200000
MAGENTA THERAPEUTICS INC MGTA 2021-09-22 12:45:03 UTC -0.2666 0.3366 1100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund MGTA -17.0 shares, $-106.76 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund MGTA -14.0 shares, $-87.92 2020-03-31 N-PORT

Elevate your investments